> 137 ng/mL) and carriage of the T allelic variant polymorphism ABCB1 rs4148738 are associated with an increased incidence of major bleeding events in patients with ACS and AF who are receiving combined antithrombotic therapy comprising rivaroxaban and clopidogrel. This evidence concerns the gene ABCB1 and atrial fibrillation.